Milestone Gallery
Milestone Overview
AI Healthcare Screening at BiotechMed 2021
The 6th BiotechMed Forum took place in Gelendzhik on October 4-5, 2021. The event served as a platform for industry experts to discuss the future of biomedical technologies, healthcare trends, and import substitution strategies. As a leading artificial intelligence authority, the iPavlov team presented solutions focused on digital transformation in medicine.
Advancing Rare Disease Diagnostics
The session highlighted the critical gap between research organizations and medical device manufacturers. The iPavlov delegation demonstrated how AI Healthcare Screening protocols analyze electronic medical records (EMR) to identify early indicators of rare genetic conditions.
Impact Metrics Reducing diagnosis time from 7 years to 2 years. Potential to lower pediatric mortality by 50%. Focusing on diseases like Mucopolysaccharidosis, Fabry, Pompe, and Niemann-Pick.
The discussion points included:
Overcoming the development gap between researchers and manufacturers.
Improving collaboration between physicians and engineers.
Transferring innovative technologies across international markets.
Optimizing Clinical Workflows
By integrating CV and NLP models into clinical workflows, the DeepTech pioneer aims to automate routine diagnostic processes. This implementation enhances the accuracy and timeliness of identifying critical health patterns within the Russian medical ecosystem, supporting clinicians in faster, data-driven decision making.